Home / Health / Stem Cells Restore Sight in Macular Degeneration Trial
Stem Cells Restore Sight in Macular Degeneration Trial
26 Nov
Summary
- Stem cell transplant safely reversed vision loss in trial participants.
- Vision improved significantly for patients with severe dry AMD.
- This innovative treatment showed promising results in early human testing.
A pioneering clinical trial has demonstrated the potential of stem cell transplants to safely reverse vision damage in individuals with age-related macular degeneration (AMD). This early-stage investigation focused on safety and initial efficacy, revealing that the procedure may offer a way to restore lost central vision.
The trial involved patients diagnosed with dry AMD, the most common form of the condition, where central vision gradually deteriorates. Researchers surgically transplanted stem cells designed to produce new retinal pigment epithelial cells, the crucial cells lost in AMD.
Results indicate the treatment is safe, with no tumor formation or immune rejection observed. Significantly, patients experienced vision improvement in the treated eye, with some of the most severely affected participants regaining substantial visual acuity. These encouraging outcomes pave the way for further, larger-scale human trials to confirm the treatment's effectiveness.
